Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.03 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Radiology/Staging/Screening
- Presentations: 84
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.03-035 - Does Screening with Low-Dose Computed Tomography (LDCT) of Asbestos Exposed Subjects Reduce Mortality for Lung Cancer (LC)?
14:30 - 14:30 | Author(s): G. Fasola
- Abstract
Loading...
-
+
P1.06 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 47
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.06-017 - Observational Study on Prolonged Disease Stabilization in Advanced NSCLC EGFR WT/Unknown Patients Treated with Erlotinib in Second Line
14:30 - 14:30 | Author(s): F. Grossi
- Abstract
Loading...
-
+
MA10 - Facing the Real World: New Staging System and Response Evaluation in Immunotherapy
- Type: Mini Oral Session
- Track: Radiology/Staging/Screening
- Presentations: 12
- Moderators:P. Kosmidis
- Coordinates: 12/06/2016, 14:20 - 15:50, Stolz 2
-
+
MA10.09 - Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response
15:20 - 15:26 | Author(s): G. Rossi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA10.11 - Comparison among Different Radiological Criteria for Assessing Response to Nivolumab in Advanced Non-Small Cell Lung Cancer
15:32 - 15:38 | Author(s): F. Grossi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 94
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.01-067 - The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
14:30 - 14:30 | Author(s): M.G. Dal Bello
- Abstract
Loading...
-
+
P3.02c - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 103
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02c-036 - Management of Early Disease Progression during Treatment of Advanced Non-Small Cell Lung Cancer with Nivolumab
14:30 - 14:30 | Author(s): C. Genova
- Abstract
Loading... -
+
P3.02c-039 - Endocrinological Side-Effects of Nivolumab in Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): G. Rossi
- Abstract
Loading... -
+
P3.02c-054 - Prognostic Role of cfDNA in Patients with NSCLC under Treatment with Nivolumab
14:30 - 14:30 | Author(s): F. Biello
- Abstract
Loading... -
+
P3.02c-072 - Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): C. Genova
- Abstract
Loading... -
+
P3.02c-074 - Evaluation of a Pretreatment Serum Tests for Nivolumab Benefit in Patients with Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): F. Grossi
- Abstract
Loading... -
+
P3.02c-077 - Cardiac Troponin-I Elevation in Patients with Non-Small Cell Lung Cancer during PD1/PDL1 Inhibition with Nivolumab
14:30 - 14:30 | Author(s): E. Rijavec
- Abstract
Loading... -
+
P3.02c-092 - Nivolumab in Multi-Treated Patients with Advanced Sq-NSCLC: Data from the Italian Cohort of Expanded Access Programme (EAP)
14:30 - 14:30 | Author(s): M. Tiseo
- Abstract
Loading... -
+
P3.02c-094 - Italian Nivolumab Advanced Squamous NSCLC Expanded Access Program: Efficacy and Safety in Patients with Brain Metastases
14:30 - 14:30 | Author(s): D.L. Cortinovis
- Abstract
Loading... -
+
P3.02c-095 - Italian Nivolumab Expanded Access Programme: Efficacy and Safety Data in Squamous Non Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): L. Crinò
- Abstract
Loading... -
+
P3.02c-096 - Use of Nivolumab in Elderly Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP)
14:30 - 14:30 | Author(s): F. Grossi
- Abstract
Loading...
